Nanomedicine is showing major promise in providing alternative methods for cancer treatment. The promise lies in the ability to combine the range of capabilities that natural biomaterials offer and the engineerability of synthetic nanoparticles.
In the new study, the research team has been able to equip an exome – part of a genome – to act as a drug delivery system for anti-cancer nanomedicines.
Results have shown that the synthetic delivery system is able to target tumours more efficiently by mimicking the human body’s cellular structures. The nanomedicine is able to spread in the body more efficiently without triggering a natural response from the immune system.
“This demonstrates the potential of the exosome-biomimetic nanoparticles to act as drug carriers to improve the anti-cancer drug efﬁcacy,” said Santos.